PRIME-XS provides European Union funded access to an infrastructure of state-of-the-art proteomics technology to the biological and biomedical research community in Europe. European researchers who would like to use proteomics technology for their research can apply with a research proposal on this website.

PRIME-XS is a consortium of twelve partners, all leading in the field of proteomics. In addition to providing access, we develop new technologies to better aid the research community in answering current day scientific questions, and organize courses and meetings.